Skip to content

Clinical trials

Completed Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Germany Clear all

361 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20019
200210
200317
200412
200515
200618
200721
200812
200920
201016
201117
201225
201328
201422
201512
201618
201711
201813
201915
202010
20215
20227
20238
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed361

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche39
Novartis Pharmaceuticals37
GBG Forschungs GmbH19
AstraZeneca16
Pfizer15
Eli Lilly and Company10
Bayer9
Women's Cancer Study Group GmbH9
Heidelberg University7
Sanofi7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms361
Neoplasms28
Neoplasm Metastasis24
Carcinoma, Non-Small-Cell Lung9
Ovarian Neoplasms8
Triple Negative Breast Neoplasms8
Colorectal Neoplasms7
Lung Neoplasms7
Prostatic Neoplasms7
Stomach Neoplasms6

Trials

Showing 1 to 25 of 361. Each trial links to its page on Pharma Observatory.

261 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.